Catheter-Associated Bloodstream Infection: a Clinical Overview of Events and Outcomes

Abstract

Objective: It aims to carry out a comprehensive review of the scientific literature on this serious complication. Through critical analysis of relevant articles, we seek to deepen knowledge about the main infection control measures, the clinical panorama of events and the impacts on patients' health.   Method: In a systematic journey through relevant databases, such as PubMed, LILACS and SCIELO, 10 studies published between 2019 and 2024 were identified and analyzed.   Results and Discussion: The incidence of ACSC varies according to several factors, such as type of catheter, insertion site, length of stay and patient characteristics. The use of long-term catheters, insertion into the subclavian vein and colonization by antibiotic-resistant microorganisms increase the risk. ACSI can manifest itself through fever, chills, sweating, hypotension and other symptoms. Diagnosis is made through blood cultures and other laboratory tests. ACSCs can lead to prolonged hospitalization, increased costs, septic shock, organ failure and death. Preventing CLABSIs is fundamental and depends on rigorous measures, such as: Recent literature offers several valuable studies that contribute to the understanding of CLABSIs. The development of risk prediction models and the implementation of prevention packages such as the PPC are promising tools for reducing the incidence of CLABSI and improving patient outcomes.   Conclusion: CLABSI represents a significant challenge, but with effective prevention and control, we can minimize its impacts and guarantee patient safety. Continuous research and implementation of best practices are essential to combat this serious complication.